Hostname: page-component-76fb5796d-2lccl Total loading time: 0 Render date: 2024-04-26T14:07:15.937Z Has data issue: false hasContentIssue false
  • English
  • Français

Role of Langerhans cells, Ki-67 protein and apoptosis in acquired cholesteatoma: prospective clinical study

Published online by Cambridge University Press:  18 January 2013

V Akdogan ,
I Yilmaz ,
T Canpolat  and
L N Ozluoglu
V Akdogan
Affiliation:
Department of Otolaryngology, Baskent University School of Medicine, Ankara, Turkey
I Yilmaz*
Affiliation:
Department of Otolaryngology, Baskent University School of Medicine, Ankara, Turkey
T Canpolat
Affiliation:
Department of Pathology, Baskent University School of Medicine, Ankara, Turkey
L N Ozluoglu
Affiliation:
Department of Otolaryngology, Baskent University School of Medicine, Ankara, Turkey
*
Address for correspondence: Dr Ismail Yilmaz, Otolaryngology Department, Baskent University, Adana Seyhan Hospital, Baraj Yolu 1 durak No 37, 01110 Seyhan, Adana, Turkey Fax: +90 322 4599197 E-mail: iy38@yahoo.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To investigate the role of Langerhans cells in the pathogenesis and clinical picture of middle-ear cholesteatoma.

Subjects and methods:

The study included 40 patients operated upon for a diagnosis of chronic otitis due to acquired cholesteatoma.

Results and analysis:

A closed surgical technique was used in 20 per cent of patients and an open technique in 80 per cent. Langerhans cells were more densely accumulated in cholesteatoma epithelium, compared with external ear canal skin (p < 0.001). Staining for Ki-67 protein was greater in cholesteatoma epithelium (p < 0.001) and Apo2.7 protein staining (indicating apoptosis) was more prominent (p < 0.001), compared with ear canal skin. Regarding significant relationships between clinical and pathological findings, staining for Ki-67 (p = 0.046) and Apo2.7 (p = 0.037) was more prominent in patients undergoing open versus closed surgery.

Conclusion:

Using cell proliferation and apoptosis markers, a dense Langerhans cell infiltration was found to occur as a host response to middle-ear cholesteatoma.

Keywords

Cell ProliferationCholesteatomaLangerhans CellsApoptosis
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 127 , Issue 3 , March 2013 , pp. 252 - 259
Copyright
Copyright © JLO (1984) Limited 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Presented at the XXXth National Congress of Turkish Otorhinolaryngology and Head and Neck Surgery, 8–12 October 2008, Antalya, Turkey

References

1Semaan, MT, Megerian, CA. The pathophysiology of cholesteatoma. Otolaryngol Clin North Am 2006;39:1143–59CrossRefGoogle ScholarPubMed
2Olszewska, E, Chodynicki, S, Chyczewski, L. Apoptosis in the pathogenesis of cholesteatoma in adults. Eur Arch Otorhinolaryngol 2006;263:409–13CrossRefGoogle ScholarPubMed
3Bujia, J, Holly, A, Sudhoff, H, Antoli-Candela, F, Tapia, MG, Kastenbauer, E. Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67. ORL J Otorhinolaryngol Relat Spec 1996;58:23–6CrossRefGoogle ScholarPubMed
4Olszewska, E, Wagner, M, Bernal-Sprekelsen, M, Ebmeyer, J, Dazert, S, Hildmann, H et al. Etiopathogenesis of cholesteatoma. Eur Arch Otorhinolaryngol 2004;261:6–24CrossRefGoogle ScholarPubMed
5Albino, AP, Kimmelman, CP, Parisier, SC. Cholesteatoma: a molecular and cellular puzzle. Am J Otol 1998;19:7–19Google ScholarPubMed
6Choufani, G, Roper, N, Delbrouck, C, Hassid, S, Gabius, HJ. Animal model for cholesteatoma induced in the gerbil: will the profiles of differentiation/growth-regulatory markers be similar to the clinical situation? Laryngoscope 2007;117:706–11CrossRefGoogle Scholar
7Gallo, O, Libonati, GA, Gallina, E, Fini-Storchi, O, Giannini, A, Urso, C et al. Langerhans cells related to prognosis in patients with laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 1991;117:1007–10CrossRefGoogle ScholarPubMed
8Gantz, BJ. Epidermal Langerhans cells in cholesteatoma. Ann Otol Rhinol Laryngol 1984;93:150–6CrossRefGoogle ScholarPubMed
9Huisman, MA, De Heer, E, Grote, JJ. Cholesteatoma epithelium is characterized by increased expression of Ki-67, p53 and p21, with minimal apoptosis. Acta Otolaryngol 2003;123:377–82CrossRefGoogle ScholarPubMed
10Raynov, AM, Moon, SK, Choung, YH, Hong, SP, Park, K. Nucleoplasm staining patterns and cell cycle-associated expression of Ki-67 in middle ear cholesteatoma. Am J Otolaryngol 2005;26:296–301CrossRefGoogle ScholarPubMed
11Mallet, Y, Nouwen, J, Lecomte-Houcke, M, Desaulty, A. Aggressiveness and quantification of epithelial proliferation of middle ear cholesteatoma by MIB1. Laryngoscope 2003;113:328–31CrossRefGoogle ScholarPubMed
12Choufani, G, Mahillon, V, Decaestecker, C, Lequeux, T, Danguy, A, Salmon, I et al. Determination of the levels of expression of sarcolectin and calcyclin and of the percentages of apoptotic but not proliferating cells to enable distinction between recurrent and nonrecurrent cholesteatomas. Laryngoscope 1999;109:1825–31CrossRefGoogle Scholar
13Ottaviani, F, Neglia, CB, Berti, E. Cytokines and adhesion molecules in middle ear cholesteatoma. A role in epithelial growth? Acta Otolaryngol 1999;119:462–7Google ScholarPubMed
14Sudhoff, H, Bujia, J, Holly, A, Kim, C, Fisseler-Eckhoff, A. Functional characterization of middle ear mucosa residues in cholesteatoma samples. Am J Otol 1994;15:217–21Google ScholarPubMed
15Takahashi, S, Nakano, Y. Immunohistochemical demonstration of Langerhans' cell in cholesteatoma using an antiserum against S-100 protein. Arch Otorhinolaryngol 1989;246:48–52CrossRefGoogle ScholarPubMed
16Kamide, Y, Sasaki, H, Abramson, M, Huang, CC. Effects of epidermal Langerhans cell's conditioned medium on keratinocytes: a role of Langerhans cells in cholesteatoma. Am J Otolaryngol 1991;12:307–15CrossRefGoogle ScholarPubMed
17Sudhoff, H, Bujia, J, Fisseler-Eckhoff, A, Schulz-Flake, C, Holly, A, Hildmann, H. Expression of the cell cycle related antigen (MIB-1) in cholesteatoma and auditory meatal skin. Laryngoscope 1995;105:1227–31CrossRefGoogle Scholar
18Olszewska, E, Chodynicki, S, Chyczewski, L, Rogowski, M. Some markers of proliferative activity in cholesteatoma epithelium in adults. Med Sci Monit 2006;12:CR337–40Google ScholarPubMed